The Ensign Group, Inc. (ENSG)
USD 132.32
(3.29%)
USD 132.32
(3.29%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.78 Billion USD | 18.64% |
| 2022 | 1.5 Billion USD | 24.39% |
| 2021 | 1.2 Billion USD | 13.79% |
| 2020 | 1.06 Billion USD | -18.19% |
| 2019 | 1.29 Billion USD | 457.27% |
| 2018 | 233.13 Million USD | -23.06% |
| 2017 | 302.99 Million USD | 9.98% |
| 2016 | 275.48 Million USD | 178.13% |
| 2015 | 99.05 Million USD | 45.07% |
| 2014 | 68.27 Million USD | -72.89% |
| 2013 | 251.89 Million USD | 25.63% |
| 2012 | 200.5 Million USD | 10.44% |
| 2011 | 181.55 Million USD | 30.19% |
| 2010 | 139.45 Million USD | 29.84% |
| 2009 | 107.4 Million USD | 80.54% |
| 2008 | 59.48 Million USD | -1.8% |
| 2007 | 60.57 Million USD | -4.73% |
| 2006 | 63.58 Million USD | 149.17% |
| 2005 | 25.52 Million USD | 0.0% |
| 2003 | 16.23 Million USD | 35.11% |
| 2002 | 12.01 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 144.53 Million USD | -0.66% |
| 2024 Q3 | 142.57 Million USD | -0.68% |
| 2024 Q2 | 143.55 Million USD | -0.67% |
| 2023 Q4 | 1.78 Billion USD | -1.09% |
| 2023 FY | 1.78 Billion USD | 18.64% |
| 2023 Q1 | 1.82 Billion USD | 21.33% |
| 2023 Q2 | 1.8 Billion USD | -1.1% |
| 2023 Q3 | 1.8 Billion USD | -0.04% |
| 2022 Q1 | 1.35 Billion USD | 12.38% |
| 2022 Q3 | 1.4 Billion USD | 3.11% |
| 2022 FY | 1.5 Billion USD | 24.39% |
| 2022 Q2 | 1.36 Billion USD | 0.61% |
| 2022 Q4 | 1.5 Billion USD | 6.7% |
| 2021 Q1 | 1.08 Billion USD | 2.13% |
| 2021 FY | 1.2 Billion USD | 13.79% |
| 2021 Q2 | 1.14 Billion USD | 5.55% |
| 2021 Q3 | 1.23 Billion USD | 7.68% |
| 2021 Q4 | 1.2 Billion USD | -1.98% |
| 2020 Q1 | 1.31 Billion USD | 1.21% |
| 2020 Q4 | 1.06 Billion USD | -0.3% |
| 2020 Q2 | 1.1 Billion USD | -16.18% |
| 2020 Q3 | 1.06 Billion USD | -3.27% |
| 2020 FY | 1.06 Billion USD | -18.19% |
| 2019 Q2 | 1.25 Billion USD | 4.36% |
| 2019 Q3 | 1.24 Billion USD | -1.28% |
| 2019 Q4 | 1.29 Billion USD | 4.76% |
| 2019 FY | 1.29 Billion USD | 457.27% |
| 2019 Q1 | 1.2 Billion USD | 416.37% |
| 2018 Q3 | 245.6 Million USD | -8.38% |
| 2018 Q4 | 233.13 Million USD | -5.08% |
| 2018 Q2 | 268.06 Million USD | -4.42% |
| 2018 FY | 233.13 Million USD | -23.06% |
| 2018 Q1 | 280.44 Million USD | -7.44% |
| 2017 Q1 | 258.47 Million USD | -6.17% |
| 2017 Q4 | 302.99 Million USD | 5.4% |
| 2017 Q3 | 287.45 Million USD | 1.05% |
| 2017 Q2 | 284.46 Million USD | 10.05% |
| 2017 FY | 302.99 Million USD | 9.98% |
| 2016 Q3 | 162.47 Million USD | -11.57% |
| 2016 FY | 275.48 Million USD | 178.13% |
| 2016 Q4 | 275.48 Million USD | 69.56% |
| 2016 Q2 | 183.72 Million USD | 26.15% |
| 2016 Q1 | 145.64 Million USD | 47.04% |
| 2015 Q4 | 99.05 Million USD | 43.12% |
| 2015 Q3 | 69.2 Million USD | 41.19% |
| 2015 Q2 | 49.01 Million USD | 1407.81% |
| 2015 Q1 | 3.25 Million USD | -95.24% |
| 2015 FY | 99.05 Million USD | 45.07% |
| 2014 FY | 68.27 Million USD | -72.89% |
| 2014 Q2 | - USD | -100.0% |
| 2014 Q3 | 3.3 Million USD | 0.0% |
| 2014 Q4 | 68.27 Million USD | 1964.68% |
| 2014 Q1 | 250.01 Million USD | -0.74% |
| 2013 Q1 | 198.68 Million USD | -0.91% |
| 2013 Q4 | 251.89 Million USD | 22.85% |
| 2013 Q2 | 206.87 Million USD | 4.12% |
| 2013 Q3 | 205.04 Million USD | -0.88% |
| 2013 FY | 251.89 Million USD | 25.63% |
| 2012 Q3 | 192.29 Million USD | -0.91% |
| 2012 Q1 | 195.82 Million USD | 7.86% |
| 2012 Q2 | 194.06 Million USD | -0.9% |
| 2012 Q4 | 200.5 Million USD | 4.27% |
| 2012 FY | 200.5 Million USD | 10.44% |
| 2011 Q1 | 138.65 Million USD | -0.57% |
| 2011 FY | 181.55 Million USD | 30.19% |
| 2011 Q4 | 181.55 Million USD | 7.99% |
| 2011 Q3 | 168.13 Million USD | 22.61% |
| 2011 Q2 | 137.12 Million USD | -1.1% |
| 2010 Q2 | 106.36 Million USD | -0.47% |
| 2010 Q4 | 139.45 Million USD | 31.75% |
| 2010 Q3 | 105.84 Million USD | -0.49% |
| 2010 FY | 139.45 Million USD | 29.84% |
| 2010 Q1 | 106.86 Million USD | -0.5% |
| 2009 Q4 | 107.4 Million USD | 83.18% |
| 2009 Q3 | 58.63 Million USD | -0.54% |
| 2009 Q2 | 58.95 Million USD | -0.39% |
| 2009 FY | 107.4 Million USD | 80.54% |
| 2009 Q1 | 59.18 Million USD | -0.52% |
| 2008 Q2 | 60.03 Million USD | -0.43% |
| 2008 FY | 59.48 Million USD | -1.8% |
| 2008 Q4 | 59.48 Million USD | -0.41% |
| 2008 Q3 | 59.73 Million USD | -0.49% |
| 2008 Q1 | 60.29 Million USD | -0.47% |
| 2007 Q1 | 63.19 Million USD | -0.62% |
| 2007 Q3 | 60.82 Million USD | -3.56% |
| 2007 FY | 60.57 Million USD | -4.73% |
| 2007 Q4 | 60.57 Million USD | -0.41% |
| 2007 Q2 | 63.07 Million USD | -0.19% |
| 2006 FY | 63.58 Million USD | 149.17% |
| 2006 Q4 | 63.58 Million USD | 0.0% |
| 2005 Q4 | 25.52 Million USD | 0.0% |
| 2005 FY | 25.52 Million USD | 0.0% |
| 2003 FY | 16.23 Million USD | 35.11% |
| 2002 FY | 12.01 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.34 Billion USD | -32.943% |
| Addus HomeCare Corporation | 124.13 Million USD | -1337.843% |
| AirSculpt Technologies, Inc. | 69.5 Million USD | -2467.98% |
| Amedisys, Inc. | 346.76 Million USD | -414.711% |
| Astrana Health, Inc. | 296.26 Million USD | -502.45% |
| Aveanna Healthcare Holdings Inc. | 1.27 Billion USD | -39.839% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 106.63 Million USD | -1573.847% |
| Cryo-Cell International, Inc. | 9.28 Million USD | -19128.914% |
| Cross Country Healthcare, Inc. | 2.66 Million USD | -66923.019% |
| COMPASS Pathways plc | 28.75 Million USD | -6106.569% |
| DocGo Inc. | 15.16 Million USD | -11671.749% |
| Healthcare Services Group, Inc. | 11.23 Million USD | -15786.275% |
| InnovAge Holding Corp. | 100.49 Million USD | -1676.014% |
| The Joint Corp. | 2 Million USD | -89141.15% |
| LifeStance Health Group, Inc. | 280.28 Million USD | -536.789% |
| Mobile-health Network Solutions Class A Ordinary Shares | 381.43 Thousand USD | -467818.33% |
| ModivCare Inc. | 983.75 Million USD | -81.429% |
| NewGenIvf Group Limited | 118.97 Thousand USD | -1500015.987% |
| Option Care Health, Inc. | 1.05 Billion USD | -68.913% |
| P3 Health Partners Inc. | 108.31 Million USD | -1547.747% |
| P3 Health Partners Inc. | 108.31 Million USD | -1547.747% |
| The Pennant Group, Inc. | 312.51 Million USD | -471.125% |
| Surgery Partners, Inc. | 2.03 Billion USD | 12.233% |
| Syra Health Corp. Class A Common Stock | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 86.82 Million USD | -1955.632% |
| The Oncology Institute, Inc. | 86.82 Million USD | -1955.632% |